Upfront F18-choline PET/CT versus Tc99m-sestaMIBI SPECT/CT guided surgery in primary hyperparathyroidism: the randomized phase III diagnostic trial APACH2.
Elske QuakAudrey Lasne CardonRenaud CiappucciniCharline LasnonVianney BastitVéronique Le HenaffBarbara LireuxGauthier FoucrasCyril JaudetCelia BerchiJean-Michel GrellardJustine LequesneBénédicte ClarisseStéphane BardetPublished in: BMC endocrine disorders (2021)
NCT04040946 , registered August 1, 2019. Protocol version Version 2.1 dated from 2020/04/23.
Keyphrases
- phase iii
- pet ct
- open label
- psychometric properties
- positron emission tomography
- clinical trial
- double blind
- placebo controlled
- phase ii
- minimally invasive
- coronary artery bypass
- randomized controlled trial
- computed tomography
- image quality
- contrast enhanced
- dual energy
- surgical site infection
- study protocol
- magnetic resonance imaging
- percutaneous coronary intervention
- magnetic resonance